Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1965 May 29;1(5447):1414–1415. doi: 10.1136/bmj.1.5447.1414

Oral Contraception and Liver-function Tests

Ulf Larsson-Cohn
PMCID: PMC2166330  PMID: 14287003

Full text

PDF
1414

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. EISALO A., JAERVINEN P. A., LUUKKAINEN T. HEPATIC IMPAIRMENT DURING THE INTAKE OF CONTRACEPTIVE PILLS: CLINICAL TRIAL WITH POSTMENOPAUSAL WOMEN. Br Med J. 1964 Aug 15;2(5406):426–427. doi: 10.1136/bmj.2.5406.426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. FOSS G. L., SIMPSON S. L. Oral methyltestosterone and jaundice. Br Med J. 1959 Jan 31;1(5117):259–263. doi: 10.1136/bmj.1.5117.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. GORDON B. S., WOLF J., KRAUSE T., SHAI F. Peliosis hepatis and cholestasis following administration of norethandrolone. Am J Clin Pathol. 1960 Feb;33:156–165. doi: 10.1093/ajcp/33.2.156. [DOI] [PubMed] [Google Scholar]
  4. LARSSON-COHN U. ORAL ANTIKONCEPTION: FYSIOLOGI JAEMTE PRELIMINAER REDOGOERELSE FOER EGET MATERIAL. Sven Lakartidn. 1964 Apr 22;61:1328–1348. [PubMed] [Google Scholar]
  5. LINTHORST G. LIVER FUNCTION AFTER LONG-TERM PROGESTATIONAL TREATMENT WITH AND WITHOUT OESTROGEN. Br Med J. 1964 Oct 10;2(5414):920–921. doi: 10.1136/bmj.2.5414.920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. MUELLER M. N., KAPPAS A. ESTROGEN PHARMACOLOGY. I. THE INFLUENCE OF ESTRADIOL AND ESTRIOL ON HEPATIC DISPOSAL OF SULFOBROMOPHTHALEIN (BSP) IN MAN. J Clin Invest. 1964 Oct;43:1905–1914. doi: 10.1172/JCI105064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. PALVA I. P., MUSTALA O. O. ORAL CONTRACEPTIVES AND LIVER DAMAGE. Br Med J. 1964 Sep 12;2(5410):688–689. doi: 10.1136/bmj.2.5410.688-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. PETERSEN K. E. [Intrahepatic biliary stasis and jaundice during treatment with methyltestosterone and methandrostenolone (Dianabol)]. Ugeskr Laeger. 1963 Mar 22;125:421–426. [PubMed] [Google Scholar]
  9. RICE-WRAY E. ORAL CONTRACEPTIVES AND LIVER DAMAGE. Br Med J. 1964 Oct 17;2(5415):1011–1011. doi: 10.1136/bmj.2.5415.1011-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. SHAW R. K., GOLD G. L. Jaundice associated with norethandrolone (nilevar) therapy. Ann Intern Med. 1960 Feb;52:428–434. doi: 10.7326/0003-4819-52-2-428. [DOI] [PubMed] [Google Scholar]
  11. SWAAB L. I. ORAL CONTRACEPTIVES AND LIVER DAMAGE. Br Med J. 1964 Sep 19;2(5411):755–755. doi: 10.1136/bmj.2.5411.755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. TYLER E. T. CURRENT STATUS OF LOS ANGELES ORAL CONTRACEPTION STUDIES. Appl Ther. 1964 Jun;6:507–511. [PubMed] [Google Scholar]
  13. WILDER E. M. Death due to liver failure following the use of methandrostenolone. Can Med Assoc J. 1962 Oct 6;87:768–769. [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES